Design and rationale of the LYS-SAF302 gene therapy study in mucopolysaccharidosis type IIIA (MPS IIIA) children
2019 ◽
Vol 126
(2)
◽
pp. S111-S112
Keyword(s):
Mps Iiia
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 123
(2)
◽
pp. S113-S114
2008 ◽
Vol 93
(4)
◽
pp. 411-418
◽